The study elucidated the fundamental role of p53 acetylation, which affects p53 ability to transcriptionally regulate its metabolic targets, such as TP53-induced glycolysis and apoptosis regulator (TIGAR), Glutaminase 2 (GLS2), and SLC7A11, and induce ferroptosis and tumor suppression. This evidence concerns the gene GLS2 and neoplasm.